Stock 688613 ALLGENS MEDICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Allgens Medical Technology CO., LTD.

Equities

688613

CNE1000051W7

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-05-13 EDT 		5-day change 1st Jan Change
14.15 CNY -0.35% Intraday chart for Allgens Medical Technology CO., LTD. -5.48% -36.43%
04-25 Allgens Medical Technology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-27 Allgens Medical Technology CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 7,368 3,123 2,968
Enterprise Value (EV) 1 6,383 2,108 1,958
P/E ratio 54.7 x 33 x 54.3 x
Yield 0.49% 0.46% -
Capitalization / Revenue 31.2 x 12.7 x 13.1 x
EV / Revenue 27 x 8.59 x 8.65 x
EV / EBITDA 52.8 x 23.2 x 41.1 x
EV / FCF 530 x 237 x -53.8 x
FCF Yield 0.19% 0.42% -1.86%
Price to Book 5.92 x 2.4 x 2.15 x
Nbr of stocks (in thousands) 133,333 133,333 133,333
Reference price 2 55.26 23.42 22.26
Announcement Date 22-04-27 23-04-20 24-04-25
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 123.7 168.6 183.8 236.1 245.3 226.5
EBITDA 1 32.75 72.2 106.6 121 91.02 47.66
EBIT 1 26.81 61.68 95.75 110.3 73.91 32.87
Operating Margin 21.68% 36.59% 52.11% 46.72% 30.13% 14.51%
Earnings before Tax (EBT) 1 34.25 74.55 102.1 132 96.2 49.09
Net income 1 32.99 67.78 88.94 120.8 95.22 54.23
Net margin 26.67% 40.21% 48.4% 51.17% 38.82% 23.95%
EPS 2 0.3400 0.6778 0.8893 1.010 0.7100 0.4100
Free Cash Flow 1 -8.732 -6.821 -27.31 12.03 8.883 -36.42
FCF margin -7.06% -4.05% -14.86% 5.1% 3.62% -16.08%
FCF Conversion (EBITDA) - - - 9.95% 9.76% -
FCF Conversion (Net income) - - - 9.96% 9.33% -
Dividend per Share - - - 0.2720 0.1070 -
Announcement Date 20-06-19 20-06-19 21-04-28 22-04-27 23-04-20 24-04-25
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 323 388 420 985 1,014 1,010
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -8.73 -6.82 -27.3 12 8.88 -36.4
ROE (net income / shareholders' equity) 7.2% 12.6% 14.3% 12.3% 7.06% 3.88%
ROA (Net income/ Total Assets) 3.96% 6.21% 7.87% 6.18% 3.2% 1.38%
Assets 1 832.2 1,091 1,130 1,955 2,973 3,941
Book Value Per Share 2 4.520 5.330 6.230 9.330 9.770 10.40
Cash Flow per Share 2 0.8900 0.7500 0.2100 3.080 1.950 1.210
Capex 1 99.5 77.1 56.4 61.2 45.4 21.9
Capex / Sales 80.46% 45.76% 30.69% 25.94% 18.52% 9.67%
Announcement Date 20-06-19 20-06-19 21-04-28 22-04-27 23-04-20 24-04-25
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
ALLGENS MEDICAL TECHNOLOGY CO., LTD. Stock Allgens Medical Technology CO., LTD.
-36.43% 266M
STRYKER CORPORATION Stock Stryker Corporation
+8.29% 124B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-5.61% 11.02B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+4.83% 8.88B
GLAUKOS CORPORATION Stock Glaukos Corporation
+39.60% 5.45B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-22.04% 4.74B
AXONICS, INC. Stock Axonics, Inc.
+8.39% 3.44B
ENOVIS CORPORATION Stock Enovis Corporation
-6.28% 2.84B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-10.23% 2.15B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-5.99% 2.11B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. 688613 Stock
  4. Financials Allgens Medical Technology CO., LTD.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW